**Core Concept**
The underlying principle being tested is the management of **idiopathic thrombocytopenic purpura (ITP)**, an autoimmune disease characterized by low platelet count due to increased platelet destruction. **Splenectomy**, or removal of the spleen, is considered in certain cases. The spleen plays a key role in platelet removal.

**Why the Correct Answer is Right**
Although the specific correct answer choice is not provided, the general reasoning for why splenectomy might benefit a patient with ITP includes the spleen's role in **antibody-mediated platelet destruction**. In ITP, the immune system produces antibodies against the patient's own platelets, marking them for destruction. The spleen, which filters the blood, recognizes and removes these antibody-tagged platelets. By removing the spleen, the site of platelet destruction is eliminated, potentially increasing platelet counts.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of option A, a general approach would be to assess if it directly relates to the pathophysiology of ITP or the role of the spleen in platelet destruction.
**Option B:** Similarly, option B would need to be evaluated for its relevance to ITP management and splenectomy benefits.
**Option C:** This option would be incorrect if it does not align with the established benefits of splenectomy in ITP, such as increased platelet count.
**Option D:** Any option that does not directly tie into the spleen's function in platelet destruction or ITP pathophysiology would be incorrect.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that splenectomy is considered for patients with ITP who have not responded to first-line treatments, such as corticosteroids. The procedure can significantly improve platelet counts in these patients, though it is not without risks and is considered on a case-by-case basis.

**Correct Answer:** Correct Answer: D. Platelet count increases after splenectomy.